ImmunoBlue
1 known investors
Find your way into ImmunoBlue
Sign up to see every warm intro you have to ImmunoBlue
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ImmunoBlue team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ImmunoBlue develops nanoimmunotherapies for cancer treatment by combining nanotechnology and immunotherapy. It operates in the biotech and therapeutics space.
Founders & leadership
Investors · 1
Frequently asked questions
- What does ImmunoBlue do?
- ImmunoBlue develops nanoimmunotherapies for cancer treatment by combining nanotechnology and immunotherapy. It operates in the biotech and therapeutics space.
- Who founded ImmunoBlue?
- ImmunoBlue was founded by Rohan Fernandes, PhD.
- Who are ImmunoBlue's investors?
- ImmunoBlue's investors include The Innovation Space.



